摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-di-O-pivaloyl-D-galactono-1,4-lactone | 153474-77-2

中文名称
——
中文别名
——
英文名称
2,6-di-O-pivaloyl-D-galactono-1,4-lactone
英文别名
[(2R)-2-[(2S,3S,4R)-4-(2,2-dimethylpropanoyloxy)-3-hydroxy-5-oxooxolan-2-yl]-2-hydroxyethyl] 2,2-dimethylpropanoate
2,6-di-O-pivaloyl-D-galactono-1,4-lactone化学式
CAS
153474-77-2
化学式
C16H26O8
mdl
——
分子量
346.378
InChiKey
FQPQXJODSQZAEK-VPOLOUISSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    24
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    119
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,6-di-O-pivaloyl-D-galactono-1,4-lactone吡啶四氯化锡 作用下, 以 二氯甲烷 为溶剂, 反应 3.17h, 生成 2,3,5,6-tetra-O-benzoyl-β-D-galactofuranosyl-(1->5)-3-O-acetyl-2,6-di-O-pivaloyl-D-galactono-1,4-lactone
    参考文献:
    名称:
    Syntheses of β-d-Galf-(1→6)-β-d-Galf-(1→5)-d-Galf and β-d-Galf-(1→5)-β-d-Galf-(1→6)-d-Galf, Trisaccharide Units in the Galactan of Mycobacterium tuberculosis
    摘要:
    The galactofuran is a crucial constituent of the cell wall of mycobacteria. An efficient synthesis of the two trisaccharide units of the galactan is described. The strategy relies on the use of substituted D-galactono-1,4-lactones as precursors for the internal and the reducing galactofuranoses. Dec-9-enyl beta-D-Galf-(1-->6)-beta-D-Galf-(1-->5)-beta-D-Galf (2) and dec-9-enyl beta-D-Galf-(1-->5)-beta-D-Galf-(1beta6)-beta-D-Galf (9) so far reported as convenient substrates for the galactofaranosyl transferase, and possibly useful for immunological studies, were obtained by the trichloroacetimidate method of glycosylation.
    DOI:
    10.1021/jo034365o
  • 作为产物:
    描述:
    三甲基乙酰氯D-半乳糖酸-1,4-内酯吡啶 作用下, 反应 5.0h, 以79%的产率得到2,6-di-O-pivaloyl-D-galactono-1,4-lactone
    参考文献:
    名称:
    Syntheses of β-d-Galf-(1→6)-β-d-Galf-(1→5)-d-Galf and β-d-Galf-(1→5)-β-d-Galf-(1→6)-d-Galf, Trisaccharide Units in the Galactan of Mycobacterium tuberculosis
    摘要:
    The galactofuran is a crucial constituent of the cell wall of mycobacteria. An efficient synthesis of the two trisaccharide units of the galactan is described. The strategy relies on the use of substituted D-galactono-1,4-lactones as precursors for the internal and the reducing galactofuranoses. Dec-9-enyl beta-D-Galf-(1-->6)-beta-D-Galf-(1-->5)-beta-D-Galf (2) and dec-9-enyl beta-D-Galf-(1-->5)-beta-D-Galf-(1beta6)-beta-D-Galf (9) so far reported as convenient substrates for the galactofaranosyl transferase, and possibly useful for immunological studies, were obtained by the trichloroacetimidate method of glycosylation.
    DOI:
    10.1021/jo034365o
点击查看最新优质反应信息

文献信息

  • Synthesis of arabinofuranose branched galactofuran tetrasaccharides, constituents of mycobacterial arabinogalactan
    作者:Lucía Gandolfi-Donadío、Malena Santos、Rosa M. de Lederkremer、Carola Gallo-Rodriguez
    DOI:10.1039/c0ob00989j
    日期:——
    Mycolyl-arabinogalactan (mAG) complex is a major component of the cell wall of Mycobacterium tuberculosis, the causative agent of tuberculosis disease. Due to the essentiality of the cell wall for mycobacterium viability, knowledge of the biosynthesis of the arabinogalactan is crucial for the development of new therapeutic agents. In this context, we have synthesized two new branched arabinogalactafuranose tetrasaccharides, decenyl β-D-Galf-(1→5)-β-D-Galf-(1→6)[α-D-Araf(1→5)]-β-D-Galf (1) and decenyl β-D-Galf-(1→6)-[α-D-Araf-(1→5)]-β-D-Galf-(1→5)-β-D-Galf (2), as interesting tools for arabinofuranosyl transferase studies. The aldonolactone strategy for the introduction of the internal D-Galf was employed, allowing the construction of oligosaccharides from the non-reducing to the reducing end. Moreover, a one-pot procedure was developed for the synthesis of trisaccharide lactone 21, precursor of 2, which involved a glycosylation-deprotection-glycosylation sequence, through the use of TMSOTf as catalyst of the trichloroacetimidate method as well as promoter of TBDMS deprotection.
    麦角糖阿拉伯半乳糖(mAG)复合物是结核分枝杆菌(Mycobacterium tuberculosis)细胞壁的重要组成部分,该菌是结核病的致病因子。由于细胞壁对分枝杆菌的生存至关重要,因此了解阿拉伯半乳糖的生物合成对于开发新的治疗药物具有重要意义。在此背景下,我们合成了两种新的分支型阿拉伯半乳糖呋喃糖四糖,分别为十烯基 β-D-Galf-(1→5)-β-D-Galf-(1→6)[α-D-Araf(1→5)]-β-D-Galf (1) 和十烯基 β-D-Galf-(1→6)-[α-D-Araf-(1→5)]-β-D-Galf-(1→5)-β-D-Galf (2),作为阿拉伯呋喃糖基转移酶研究的有趣工具。采用了醇内酯策略引入内源性 D-Galf,使得可以从非还原端到还原端构建寡糖。此外,还开发了一种一锅法合成三糖内酯 21,它是 2 的前体,该方法涉及到糖苷化-去保护-糖苷化序列,采用 TMSOTf 作为三氯乙酰胺法的催化剂,以及 TBDMS 去保护的促进剂。
  • Facile synthesis of α-<scp>D</scp>-Ara<i>f-</i>(1→5)-<scp>D</scp>-Gal<i>f</i>, the linker unit of the arabinan to the galactan in <i>Mycobacterium tuberculosis</i>
    作者:Lucía Gandolfi-Donadío、Carola Gallo-Rodriguez、Rosa M de Lederkremer
    DOI:10.1139/v06-025
    日期:2006.4.1

    The arabinogalactan is a crucial constituent of the cell wall of mycobacteria. Both monosaccharides (arabinose and galactose) are found in the furanose configuration, absent in mammals. An efficient synthesis of α-D-Araf-(1→5)-D-Galf, the linker unit of the arabinan to the galactan, is described. The strategy relies on the use of a conveniently substituted D-galactono-1,4-lactone as a precursor of the reducing furanose ring. The glycosylation step was performed by the tin(IV) chloride promoted method using 1,2,3,5-tetra-O-benzoyl-α,β-D-arabinofuranose. The arabinose donor was obtained in a crystalline state in one step by benzoylation of arabinose in hot pyridine. Selective glycosylation of the exocyclic OH-5 was obtained in 75% yield to give 2,3,5-tri-O-benzoyl-α-D-arabinofuranosyl-(1→5)-2,6-di-O-pivaloyl-D-galactono-1,4-lactone. Reduction with disiamylborane gave the disaccharide synthon, useful for further glycosylations. Dec-9-enyl α-D-Araf-(1→5)-β-D-Galf, a convenient substrate for arabinofuranosyl transferases studies, was obtained by the trichloroacetimidate method of glycosylation.Key words: arabinofuranose, galactofuranose, Mycobacterium arabinogalactan, trichloroacetimidate, tin(IV) chloride.

    阿拉伯半乳聚糖是分枝杆菌细胞壁的重要成分。这两种单糖(阿拉伯糖和半乳糖)都以呋喃糖构型存在,哺乳动物中没有这种构型。本文介绍了阿拉伯聚糖与半乳糖的连接单元 α-D-Araf-(1→5)-D-Galf 的高效合成方法。该策略依赖于使用方便取代的 D-半乳糖-1,4-内酯作为还原呋喃糖环的前体。糖基化步骤是通过氯化锡(IV)促进法使用 1,2,3,5-四-O-苯甲酰基-α,β-D-阿拉伯呋喃糖进行的。通过在热吡啶中对阿拉伯糖进行苯甲酰化,一步即可获得结晶状态的阿拉伯糖供体。外环 OH-5 的选择性糖基化得到 2,3,5-三-O-苯甲酰基-α-D-阿拉伯呋喃糖基-(1→5)-2,6-二-O-特戊酰基-D-半乳糖-1,4-内酯,收率为 75%。用二甲基硼烷还原可得到二糖合子,有助于进一步的糖基化。通过三氯乙酰亚氨酸糖基化方法获得了α-D-Araf-(1→5)-β-D-Galf Dec-9-烯基,这是一种方便的阿拉伯呋喃糖基转移酶研究底物。
  • Synthesis of a tetrasaccharide fragment of mycobacterial arabinogalactan
    作者:Lucía Gandolfi-Donadío、Carola Gallo-Rodriguez、Rosa M. de Lederkremer
    DOI:10.1016/j.carres.2008.01.024
    日期:2008.7
    conveniently derivatized for further elongation. The strategy relied on the use of suitably substituted D-galactono-1,4-lactones as precursors for the galactofuranose units. Reduction of lactone tetrasaccharide 9 with disiamylborane afforded the tetrasaccharide synthon 1. The tetrasaccharide contains the linker unit of the arabinan to the galactan.
    分枝杆菌的阿拉伯半乳聚糖含有呋喃糖环形式的两种单糖,在哺乳动物中不存在。我们在这里报告四糖片段α-D-Araf-(1-> 5)-beta-D-Galf-(1-> 5)-beta-D-Galf-(1-> 6的首次合成)-D-Galf,可方便地衍生化以进一步延长。该策略依赖于使用适当取代的D-半乳糖-1,4-内酯作为半乳糖呋喃糖单元的前体。用二戊基硼烷还原内酯四糖9得到四糖合成子1。四糖含有阿拉伯聚糖与半乳聚糖的连接单元。
  • Gallo, Carola; Jeroncic, Lucio O.; Varela, Oscar, Journal of Carbohydrate Chemistry, 1993, vol. 12, # 7, p. 841 - 852
    作者:Gallo, Carola、Jeroncic, Lucio O.、Varela, Oscar、Lederkremer, Rosa M. de
    DOI:——
    日期:——
  • Syntheses of β-<scp>d</scp>-Gal<i>f</i>-(1→6)-β-<scp>d</scp>-Gal<i>f</i>-(1→5)-<scp>d</scp>-Gal<i>f</i> and β-<scp>d</scp>-Gal<i>f</i>-(1→5)-β-<scp>d</scp>-Gal<i>f</i>-(1→6)-<scp>d</scp>-Gal<i>f</i>, Trisaccharide Units in the Galactan of <i>Mycobacterium </i><i>t</i><i>uberculosis</i>
    作者:Lucía Gandolfi-Donadío、Carola Gallo-Rodriguez、Rosa M. de Lederkremer
    DOI:10.1021/jo034365o
    日期:2003.9.1
    The galactofuran is a crucial constituent of the cell wall of mycobacteria. An efficient synthesis of the two trisaccharide units of the galactan is described. The strategy relies on the use of substituted D-galactono-1,4-lactones as precursors for the internal and the reducing galactofuranoses. Dec-9-enyl beta-D-Galf-(1-->6)-beta-D-Galf-(1-->5)-beta-D-Galf (2) and dec-9-enyl beta-D-Galf-(1-->5)-beta-D-Galf-(1beta6)-beta-D-Galf (9) so far reported as convenient substrates for the galactofaranosyl transferase, and possibly useful for immunological studies, were obtained by the trichloroacetimidate method of glycosylation.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物